Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. WVE
WVE logo

WVE

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

WVE News

Wave Life Sciences Under Investigation for Securities Violations

3d agoGlobenewswire

Biotech Sector Regulatory Approvals and Collaborations

May 22 2026NASDAQ.COM

AlphaDetect Partners with Wave Life Sciences to Enhance Detection Efforts

May 19 2026Newsfilter

Wave Life Sciences Sponsors AlphaDetect to Enhance Detection Efforts

May 19 2026PRnewswire

Wave Life Sciences Reports Positive Early Results for WVE-006 Treatment

May 18 2026stocktwits

WVE-006 Shows Significant Potential in Treating AAT Deficiency

May 18 2026Newsfilter

Wave Life Sciences Q1 Earnings Exceed Expectations

Apr 28 2026seekingalpha

Wave Life Sciences Reports Q1 2026 Financial Results and Business Updates

Apr 28 2026Newsfilter

Wave Life Sciences to Host Q1 2026 Financial Results Call on April 28

Apr 22 2026Newsfilter

Wave Life Sciences' Weight Loss Drug Fails Phase 1 Study

Apr 01 2026NASDAQ.COM

Wave Life Sciences Phase 1 Trial Results Disappoint Investors

Apr 01 2026Fool

Wave Life Sciences Shares Surge 9.5% Amid Trading Volume Spike

Apr 01 2026NASDAQ.COM

WAVE LIFE SCIENCES LTD: WEDBUSH REDUCES TARGET PRICE FROM $35 TO $15

Mar 27 2026moomoo

Wave Life Sciences Shares Plunge 49.59% After Disappointing Data

Mar 26 2026Fool

Wave Life Sciences Shares Plunge Nearly 50% After Disappointing Data

Mar 26 2026NASDAQ.COM

Wave Life and Golar LNG See Active Options Trading

Mar 26 2026NASDAQ.COM